IMG_1337 (1).jpg


Head of Compound Discovery

Mark completed his undergraduate and masters in Biochemistry at the University of Oxford. He then completed an MSc and PhD at Imperial College London, where he developed a biosynthetic platform for antimalarial drug discovery and a single molecule method for studying protein folding. Before joining Baccuico, he was based at the Drug Discovery Unit at GlaxoSmithKline in Madrid.

Mark joined Baccuico in London in September 2020 and is leading the screening and automation team for the discovery of novel antibiotics.

Outside of the lab, Mark can be found in the kitchen cooking and baking, or travelling around the world on his bike.